PRP for Hair Loss: The Mechanism, Evidence, and Honest Limits

Platelet-rich plasma (PRP) for hair restoration occupies an interesting space — it has solid mechanistic logic, a meaningful but not miraculous evidence base, and is often oversold in marketing copy. This article walks through what PRP actually does at the follicle, what the controlled-trial literature supports, and how candidate evaluation should be structured.

For the program at SkinArtMD in Burnaby, BC, see the PRP hair restoration service page. To assess fit, book a consultation with our medical team.

Mechanism of Action: What PRP Does at the Follicle

Platelets are not just clotting agents. Their alpha granules contain a concentrated cocktail of growth factors and cytokines — PDGF, VEGF, IGF-1, EGF, TGF-beta — that participate in tissue repair and stem cell signalling. PRP preparation centrifuges autologous whole blood to concentrate these platelets several-fold above baseline, then injects the supernatant into the target tissue.

In the scalp, three follicle-relevant effects have been demonstrated in vitro and in animal models:

1. Anagen phase extension. PRP-derived growth factors stimulate dermal papilla cells, the cluster of mesenchymal cells at the follicle base that controls hair cycle. Active dermal papilla = longer growth phase = thicker, longer hair shaft per cycle.
2. Follicle stem cell activation. Bulge region stem cells receive proliferative signals via PDGF and Wnt-pathway crosstalk. Dormant follicles can re-enter active growth.
3. Microvasculature support. VEGF promotes localised angiogenesis. Better follicular blood supply correlates with healthier hair shaft production.

PRP does not create new follicles. The follicle inventory is fixed. PRP works by improving the function of follicles that still exist, including those that have miniaturised but not been lost.

Clinical Evidence: What Trials Show

The PRP-for-hair literature has matured over the last decade. Key studies:

• Gentile et al. (Stem Cells Translational Medicine). Randomised half-head trial in male androgenetic alopecia showed significantly higher hair count and density on the PRP-treated side at 6 months versus placebo.
• Cervelli et al. (BioMed Research International). Demonstrated similar hair count gains with three monthly sessions.
• Alves and Grimalt (Dermatologic Surgery). Reviewed 19 studies; concluded benefit is most consistent in early-to-moderate androgenetic alopecia and that protocol heterogeneity (single versus double-spin, activator versus no activator) likely contributes to mixed results across studies.

What the literature does not support: dramatic regrowth in advanced loss, success in scarring alopecia, or substitute status for medical workup of underlying conditions (thyroid disease, iron deficiency, autoimmune alopecia).

PRP is a regulated medical procedure in Canada. Health Canada classifies autologous PRP preparation as a medical practice rather than a drug.

Comparison to Adjacent Mechanisms

• Topical minoxidil prolongs anagen phase via vasodilation and direct follicle effects. Effective for many patients; daily commitment required.
• Oral finasteride / dutasteride blocks 5-alpha reductase, reducing scalp DHT — the hormone driver in androgenetic alopecia. Most effective single intervention for genetically driven loss; requires medical evaluation for candidacy and side-effect profile.
• Exosome therapy delivers a different signalling payload (lipid-bound RNAs and proteins from mesenchymal stem cells). Less long-term data than PRP.
• Hair transplant surgery redistributes existing follicles. The total follicle count does not change, but density in cosmetically important zones can be increased.

In practice, the best outcomes come from combining mechanisms: PRP plus minoxidil, or PRP after starting finasteride for genetically driven loss. Single-modality approaches underperform integrated plans.

Candidate Evaluation

PRP works best for:

• Early-to-moderate androgenetic alopecia (Norwood I-IV / Ludwig I-II).
• Telogen effluvium that has not resolved with treatment of the underlying cause.
• Diffuse thinning without distinct patterning.

PRP works less well or is inappropriate for:

• Advanced loss (Norwood VI-VII): too few viable follicles remain to respond.
• Scarring alopecias (lichen planopilaris, frontal fibrosing alopecia, central centrifugal cicatricial alopecia): require medical (often immunosuppressive) management; PRP alone is insufficient.
• Active scalp inflammation or infection.
• Bleeding disorders, anticoagulation, or platelet dysfunction.

A proper consultation includes:

• Family history and pattern assessment.
• Bloodwork (CBC, ferritin, vitamin D, thyroid, hormones if indicated).
• Trichoscopy where available.
• Discussion of expectations and integration with medical therapies.

At SkinArtMD, this evaluation is led by Dr. Sharon Fong (CPSBC registered).

Limitations and Realistic Expectations

• Visible change takes 3-6 months. The hair cycle is slow.
• Maintenance is required. Most clinical responders need a session every 4-6 months after the initial 3-4 session loading phase to sustain results.
• Response varies. Some patients see meaningful density gains; others see stabilisation without dramatic regrowth. A clinic that promises uniform dramatic results is overstating.
• Combination therapy outperforms PRP alone. A reasonable program includes minoxidil and, where appropriate, oral medical therapy.

Frequently Asked Questions

How many sessions will I need? Standard induction is 3-4 sessions at 4-6 week intervals. Maintenance is typically every 4-6 months thereafter. Individual response determines actual schedule.

Does it hurt? The scalp is anaesthetised before injection. Most patients describe pressure rather than pain. Mild post-procedure tenderness is common and usually resolves within 24 hours.

When will I see results? Visible change typically emerges between months 3 and 6. Photo documentation at baseline and 6 months is the most reliable comparator.

Can I combine PRP with minoxidil? Yes — and this is the more effective approach for most patients with androgenetic alopecia. Minoxidil and PRP have complementary mechanisms.

Is PRP suitable for women? Yes, particularly for diffuse thinning patterns. Hormonal evaluation (thyroid, iron, androgens) precedes PRP for female patients.

Why Choose SkinArtMD

SkinArtMD in Burnaby, BC provides physician-supervised PRP under the care of Dr. Sharon Fong (CPSBC registered). Protocols are individualised after baseline workup, and we structure programs to combine PRP with appropriate medical therapy rather than offering it as a stand-alone marketing package. Bilingual care available in English and Mandarin.

Next Steps

The useful next step is a focused consultation with bloodwork and a candid conversation about pattern, severity, and realistic outcomes. Book your consultation today.

This article is for educational purposes only and does not constitute medical advice. Please consult with a qualified healthcare professional before undergoing any treatment.